89bio Historical Financial Ratios
| ETNB Stock | USD 8.99 0.15 1.64% |
89bio is presently reporting on over 93 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 0.74 or Days Sales Outstanding of 0.0 will help investors to properly organize and evaluate 89bio Inc financial condition quickly.
89bio |
About 89bio Financial Ratios Analysis
89bio IncFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate 89bio investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on 89bio financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across 89bio history.
89bio Financial Ratios Chart
Add Fundamental
Invested Capital
Invested capital represents the total cash investment that shareholders and debt holders have contributed to 89bio Inc. There are two different methods for calculating 89bio Inc invested capital: operating approach and financing approach. Understanding 89bio invested capital allows investors to calculate measures of performance such as return on invested capital or return on capital employed.Payables Turnover
A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.Average Inventory
The average amount of inventory a company holds over a certain period, which is used to calculate inventory turnover and efficiency in managing stock levels.Return On Equity
Return on Equity is the amount of 89bio Inc net income returned as a percentage of 89bio equity. Return on equity measures 89bio profitability by revealing how much profit 89bio Inc generates with the money shareholders have invested. A measure of the profitability of a business in relation to the equity, calculated by dividing net income by shareholder's equity.Most ratios from 89bio's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into 89bio Inc current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in 89bio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At present, 89bio's Payables Turnover is projected to increase slightly based on the last few years of reporting. The current year's Graham Number is expected to grow to 25.44, whereas PTB Ratio is forecasted to decline to 0.74.
89bio fundamentals Correlations
Click cells to compare fundamentals
89bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
89bio fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Ptb Ratio | 3.11 | 1.93 | 2.09 | 2.92 | 1.48 | 0.74 | |
| Book Value Per Share | 8.45 | 12.62 | 6.27 | 4.36 | 7.54 | 4.77 | |
| Free Cash Flow Yield | (0.0915) | (0.12) | (0.29) | (0.18) | (0.16) | (0.17) | |
| Operating Cash Flow Per Share | (2.39) | (2.87) | (3.82) | (2.33) | (1.82) | (1.91) | |
| Capex To Depreciation | 8.18 | 2.1 | 0.8 | 0.11 | 0.08 | 0.076 | |
| Pb Ratio | 3.11 | 1.93 | 2.09 | 2.92 | 1.48 | 0.74 | |
| Free Cash Flow Per Share | (2.41) | (2.88) | (3.82) | (2.33) | (1.82) | (1.91) | |
| Roic | (0.3) | (0.24) | (0.62) | 0.6 | (0.28) | (0.26) | |
| Net Income Per Share | (5.4) | (3.08) | (4.48) | (2.93) | (2.0) | (2.1) | |
| Payables Turnover | 0.0172 | 0.0291 | 0.0115 | 0.0192 | 0.0318 | 0.0334 | |
| Cash Per Share | 8.78 | 19.34 | 12.39 | 5.41 | 8.13 | 7.54 | |
| Pocfratio | (10.98) | (8.48) | (3.42) | (5.46) | (6.15) | (6.46) | |
| Capex To Operating Cash Flow | (0.00546) | (0.002725) | (8.21E-4) | (8.6E-5) | (3.1E-5) | (3.3E-5) | |
| Pfcf Ratio | (10.93) | (8.46) | (3.42) | (5.46) | (6.15) | (6.46) | |
| Days Payables Outstanding | 21.2K | 12.6K | 31.6K | 19.0K | 11.5K | 10.9K | |
| Income Quality | 0.44 | 0.93 | 0.85 | 0.79 | 0.91 | 0.62 | |
| Roe | (0.64) | (0.24) | (0.72) | (0.67) | (0.27) | (0.28) | |
| Ev To Operating Cash Flow | (7.32) | (4.05) | (1.71) | (5.03) | (3.92) | (4.11) | |
| Pe Ratio | (4.87) | (7.92) | (2.91) | (4.34) | (5.59) | (5.87) | |
| Return On Tangible Assets | (0.6) | (0.23) | (0.55) | (0.52) | (0.24) | (0.25) | |
| Ev To Free Cash Flow | (7.28) | (4.04) | (1.71) | (5.03) | (3.92) | (4.11) | |
| Earnings Yield | (0.21) | (0.13) | (0.34) | (0.23) | (0.18) | (0.19) | |
| Net Debt To E B I T D A | 1.63 | 4.13 | 1.46 | 0.35 | 2.15 | 1.18 | |
| Current Ratio | 17.0 | 25.91 | 8.29 | 7.97 | 20.04 | 10.9 | |
| Tangible Book Value Per Share | 8.45 | 12.62 | 6.27 | 4.36 | 7.54 | 4.77 | |
| Graham Number | 32.04 | 29.55 | 25.15 | 16.96 | 18.4 | 25.44 | |
| Shareholders Equity Per Share | 8.45 | 12.62 | 6.27 | 4.36 | 7.54 | 4.77 | |
| Capex Per Share | 0.0131 | 0.007832 | 0.003135 | 2.01E-4 | 5.6E-5 | 5.3E-5 | |
| Graham Net Net | 8.25 | 18.83 | 10.58 | 4.11 | 7.29 | 6.07 | |
| Enterprise Value Over E B I T D A | (3.26) | (3.79) | (1.46) | (4.09) | (3.76) | (3.95) | |
| Price Earnings Ratio | (4.87) | (7.92) | (2.91) | (4.34) | (5.59) | (5.87) | |
| Price Book Value Ratio | 3.11 | 1.93 | 2.09 | 2.92 | 1.48 | 0.74 | |
| Days Of Payables Outstanding | 21.2K | 12.6K | 31.6K | 19.0K | 11.5K | 10.9K | |
| Price To Operating Cash Flows Ratio | (10.98) | (8.48) | (3.42) | (5.46) | (6.15) | (6.46) | |
| Price To Free Cash Flows Ratio | (10.93) | (8.46) | (3.42) | (5.46) | (6.15) | (6.46) | |
| Ebt Per Ebit | 2.15 | 1.0 | 1.01 | (1.0) | 0.91 | 0.95 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether 89bio Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of 89bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of 89bio Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on 89bio Inc Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in 89bio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 89bio. If investors know 89bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 89bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.96) | Return On Assets (0.41) | Return On Equity (0.73) |
The market value of 89bio Inc is measured differently than its book value, which is the value of 89bio that is recorded on the company's balance sheet. Investors also form their own opinion of 89bio's value that differs from its market value or its book value, called intrinsic value, which is 89bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 89bio's market value can be influenced by many factors that don't directly affect 89bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 89bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if 89bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 89bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.